TRINITY BIOTECH PUBLIC LIMITED COMPANY
TRINITY BIOTECH PUBLIC LIMITED COMPANY is a public limited company registered in Ireland under company number 183476. It was incorporated on 22 January 1992 and is recorded with active (“Normal”) status on the Companies Registration Office (CRO) register, with no overdue filings. The company’s registered office is at IDA Business Park, Bray, County Wicklow, A98 H5C8, Ireland.
Trinity Biotech plc describes itself, in its filings with the US Securities and Exchange Commission, as a commercial-stage biotechnology company focused on human diagnostics and diabetes management, including wearable biosensors. It develops, manufactures and markets diagnostic test systems for infectious diseases and other clinical parameters, such as Hemoglobin A1c, for point-of-care and clinical laboratory markets, selling through a direct US operation and international distributors in more than 75 countries. Its American Depositary Shares trade on the Nasdaq Global Select Market under the ticker TRIB.
For the year ended 31 December 2025, Trinity Biotech plc reported consolidated group revenue of approximately US$43.8 million, down from US$61.6 million in 2024, alongside a consolidated net loss of approximately US$37.4 million. In 2026 the company disclosed the acquisition of biosensor technology from Waveform Technologies Inc. to support development of continuous glucose monitoring devices and related services. Separately, Nasdaq notified the company in March 2025 that it did not meet the minimum US$1.00 bid-price requirement (deadline extended to 10 August 2026) and in February 2026 that it did not meet the minimum US$15 million market-value-of-publicly-held-shares requirement (deadline 18 August 2026); its ADSs continue to trade on the Nasdaq Global Select Market pending the outcome.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
Shareholders of TRINITY BIOTECH PUBLIC LIMITED COMPANY
As a Nasdaq-listed public company, Trinity Biotech plc’s shareholder base is disclosed only through beneficial-ownership filings made with the US Securities and Exchange Commission (SEC) covering holders that cross the 5% reporting threshold, rather than through a complete shareholder register. The most recent Schedule 13D on record was filed 9 February 2024, reporting a 30 January 2024 event date, jointly by Perceptive Advisors LLC, Perceptive Credit Advisors LLC, Perceptive Credit Holdings III, L.P. and Joseph Edelman. The group reported shared (not sole) voting and dispositive power over 56,000,000 Class A Ordinary Shares, equal to 26.8% of the class at that date; no filer reported individual sole control. No other Schedule 13D or 13G naming a different beneficial owner was identified during this research. Trinity Biotech plc’s shareholders subsequently approved, at the annual general meeting held 30 September 2025, a reduction in the nominal value of ordinary shares from US$0.0109 to US$0.0001 and a large increase in authorised share capital; the share count and resulting percentage in the February 2024 filing therefore predate this capital restructuring and should be treated as historical rather than current.
Data availability
Classification: Major shareholders only / Historical. Ireland’s Companies Registration Office does not separately publish a shareholder register for Trinity Biotech plc beyond standard CRO company filings; the shareholder information above is drawn instead from SEC beneficial-ownership disclosures, which capture only holders crossing the 5% reporting threshold and, in this case, predate the company’s September 2025 share-capital restructuring. No verified ultimate beneficial owner could be identified: the February 2024 filing reports shared, not sole, voting and dispositive power across four reporting persons.
Sources
- SEC – Schedule 13D, Trinity Biotech plc, filed 9 February 2024 (Perceptive Advisors LLC, Perceptive Credit Advisors LLC, Perceptive Credit Holdings III, L.P., Joseph Edelman)
- SEC EDGAR – Trinity Biotech plc filings, CIK 0000888721
- Trinity Biotech plc – Report of Annual General Meeting resolutions, 30 September 2025 (Form 6-K)
Officers
41
Directors and officers of TRINITY BIOTECH PUBLIC LIMITED COMPANY
Trinity Biotech plc’s official investor-relations website, reviewed 18 September 2026, lists four board members. John Gillard serves as Chief Executive Officer, President and Executive Director, a role he assumed in December 2023, and is also named as the company’s Secretary; Ronan O’Caoimh, the company’s founder, remains a Director after stepping down from executive management in 2022; Dr Andrew Omidvar joined the board in December 2023; and John Paul Tivnan also serves as a Director. This current board differs from the historical Irish CRO officer filing history associated with this profile, which records director appointments and resignations dating back to the company’s 1992 incorporation and does not reflect current board composition. Nationality and country of residence for the current directors were not confirmed from an official registry source during this research and are not stated here.
Data availability
Classification: Partial. Current board composition is drawn from Trinity Biotech plc’s own investor-relations website rather than a CRO officer filing; as a US-reporting foreign private issuer, very recent (2026) board changes may not yet be reflected on that page, and nationality or country-of-residence data is not published by either source reviewed.
Sources
- Trinity Biotech plc – Board of Directors & Leadership, trinitybiotech.com/investor-relations/board-of-directors/, retrieved 18 September 2026
Registry feed — rows exactly as filed with Companies Registration Office (CRO), including entries the profile above does not cover.
Group Structure
Group structure of TRINITY BIOTECH PUBLIC LIMITED COMPANY
TRINITY BIOTECH PUBLIC LIMITED COMPANY is the ultimate parent of the Trinity Biotech group; no disclosed corporate parent controls it, and its Class A Ordinary Shares trade as American Depositary Shares on the Nasdaq Global Select Market. Trinity Biotech plc’s US Securities and Exchange Commission filings (Form 20-F for the year ended 31 December 2025, Note 32 to the consolidated financial statements) confirm three significant, wholly owned Irish subsidiaries, each registered at the same IDA Business Park, Bray, County Wicklow address as the parent: Trinity Biotech Manufacturing Limited, which manufactures and sells diagnostic test kits; Trinity Research Limited, which carries out research and development; and Trinity Biotech Manufacturing Services Limited, which is dormant. Group information reflects the FY2025 Form 20-F, reviewed 18 September 2026.
Verified corporate relationships
| Entity | Country | Registration number | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|---|
| Trinity Biotech Manufacturing Limited | IE | 239206 | Direct subsidiary | 100% (Group holding) | Active | FY2025 Form 20-F |
| Trinity Research Limited | IE | 199041 | Direct subsidiary | 100% (Group holding) | Active | FY2025 Form 20-F |
| Trinity Biotech Manufacturing Services Limited | IE | 406224 | Direct subsidiary | 100% (Group holding) | Dormant | FY2025 Form 20-F |
Recent structural changes
- Divestiture of the Fitzgerald Industries diagnostics distribution business, completed April 2023, reported in Trinity Biotech plc’s Form 20-F as generating a gain of approximately US$12.7 million (source: SEC Form 20-F).
Data availability
Classification: Partial. Trinity Biotech plc’s SEC Form 20-F discloses only subsidiaries the company treats as “significant” under SEC rules. Corporate-linkage data already associated with this profile additionally lists a wider set of entities across Ireland, the United States, Sweden, Slovenia, the United Kingdom, Luxembourg and Canada; these could not be independently confirmed as current subsidiaries from the primary SEC and CRO sources reviewed in this research pass and are therefore omitted from the verified table above rather than presented as confirmed.
Sources
- SEC – Trinity Biotech plc, Form 20-F for the year ended 31 December 2025, Note 32 (list of significant subsidiaries), CIK 0000888721
- Irish Companies Registration Office (CRO) company number 239206, Trinity Biotech Manufacturing Limited, Bray
Registry feed — rows exactly as filed with Companies Registration Office (CRO), including entries the profile above does not cover.
TRINITY BIOTECH PUBLIC LIMITED COMPANY
Ireland
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What does TRINITY BIOTECH PUBLIC LIMITED COMPANY do?
TRINITY BIOTECH PUBLIC LIMITED COMPANY (CRO number 183476) is an Irish public limited company, incorporated 22 January 1992 and registered at IDA Business Park, Bray, County Wicklow; trading as Trinity Biotech plc, it is a commercial-stage biotechnology company developing, manufacturing and marketing diagnostic test systems for infectious diseases and other clinical parameters, plus diabetes-management biosensors, sold through a direct US operation and distributors in more than 75 countries.
Who owns TRINITY BIOTECH PUBLIC LIMITED COMPANY?
The most recent SEC Schedule 13D on record, filed 9 February 2024, reported Perceptive Advisors LLC, Perceptive Credit Advisors LLC, Perceptive Credit Holdings III, L.P. and Joseph Edelman jointly holding shared voting and dispositive power over 56,000,000 Class A Ordinary Shares (26.8% of the class) as of 30 January 2024; this predates a September 2025 shareholder-approved reduction in nominal share value and increase in authorised share capital, so the percentage should be treated as historical.
Who is TRINITY BIOTECH PUBLIC LIMITED COMPANY's UBO (Ultimate Beneficial Owner)?
No Ultimate Beneficial Owner (UBO) data is recorded for TRINITY BIOTECH PUBLIC LIMITED COMPANY; access to beneficial-ownership data in this jurisdiction is governed by its own register rules.
What is TRINITY BIOTECH PUBLIC LIMITED COMPANY's company registration number?
TRINITY BIOTECH PUBLIC LIMITED COMPANY's registration number is IE183476, filed with Companies Registration Office (CRO) in Ireland. Its current status on the register is active.
Is TRINITY BIOTECH PUBLIC LIMITED COMPANY still an active company?
TRINITY BIOTECH PUBLIC LIMITED COMPANY's status on Companies Registration Office (CRO) is listed as active.
When was TRINITY BIOTECH PUBLIC LIMITED COMPANY incorporated?
TRINITY BIOTECH PUBLIC LIMITED COMPANY was incorporated on 22 January 1992, according to Companies Registration Office (CRO).
What is TRINITY BIOTECH PUBLIC LIMITED COMPANY's registered address?
The registered address on file for TRINITY BIOTECH PUBLIC LIMITED COMPANY is Ireland.
What legal structure is TRINITY BIOTECH PUBLIC LIMITED COMPANY registered as?
TRINITY BIOTECH PUBLIC LIMITED COMPANY is registered as a Public Limited Company in Ireland.
What is TRINITY BIOTECH PUBLIC LIMITED COMPANY's revenue?
Trinity Biotech plc reported consolidated group revenue of approximately US$43.8 million for the year ended 31 December 2025, down from US$61.6 million in 2024, alongside a consolidated net loss of approximately US$37.4 million.
Is TRINITY BIOTECH PUBLIC LIMITED COMPANY listed on a stock exchange?
Trinity Biotech plc's American Depositary Shares trade on the Nasdaq Global Select Market under ticker TRIB; Nasdaq notified the company in March 2025 of non-compliance with the minimum bid-price rule (extended deadline 10 August 2026) and in February 2026 of non-compliance with the minimum market-value-of-publicly-held-shares rule (deadline 18 August 2026).
Who are the officers/directors of TRINITY BIOTECH PUBLIC LIMITED COMPANY?
Trinity Biotech plc's investor-relations website, reviewed 18 September 2026, names four current board members: John Gillard (CEO, President and Executive Director since December 2023), founder Ronan O'Caoimh (Director), Dr Andrew Omidvar (Director since December 2023) and John Paul Tivnan (Director).
Does TRINITY BIOTECH PUBLIC LIMITED COMPANY have a parent company or subsidiaries?
Trinity Biotech plc is the ultimate parent of the Trinity Biotech group; its FY2025 Form 20-F confirms three wholly owned, significant Irish subsidiaries at the same Bray, County Wicklow address – Trinity Biotech Manufacturing Limited, Trinity Research Limited and the dormant Trinity Biotech Manufacturing Services Limited.
Can Zavia monitor changes to TRINITY BIOTECH PUBLIC LIMITED COMPANY's ownership over time?
This profile reflects a point-in-time snapshot from Companies Registration Office (CRO). Zavia's monitoring API can track changes to TRINITY BIOTECH PUBLIC LIMITED COMPANY's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access TRINITY BIOTECH PUBLIC LIMITED COMPANY's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Ireland, so records like TRINITY BIOTECH PUBLIC LIMITED COMPANY's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies Registration Office (CRO) and was last synced on 18 September 2026.